(Q35704112)

9 August 2017

1 reference

title

Vaccination for glaucoma: dream or reality? (English)

1 reference

9 August 2017

Michal Schwartz

1 reference

9 August 2017

publication date

1 February 2004

1 reference

9 August 2017

published in

Brain Research Bulletin

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

9 August 2017

page(s)

481-484

1 reference

Disappearance of astrocytes and invasion of macrophages following crush injury of adult rodent optic nerves: implications for regeneration

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Morphological aspects of spinal cord autoimmune neuroprotection: colocalization of T cells with B7--2 (CD86) and prevention of cyst formation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Pharmacological strategies in CNS trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Autoimmune T cells as potential neuroprotective therapy for spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

T-lymphocyte entry into the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Introductory comments on neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

The tissue-specific self-pathogen is the protective self-antigen: the case of uveitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Differential T cell response in central and peripheral nerve injury: connection with immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Autoimmune T cells retard the loss of function in injured rat optic nerves

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Physiological approaches to neuroprotection. boosting of protective autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

'Axogenic' and 'somagenic' neurodegenerative diseases: definitions and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Unraveling immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Self-Protective mechanism awakened by glutamate in retinal ganglion cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Protective autoimmunity is a physiological response to CNS trauma.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

NMDA-Receptor Antagonist Protects Neurons from Secondary Degeneration after Partial Optic Nerve Crush

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

Potential neuroprotective therapy for glaucomatous optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900073-X

7 January 2021

10.1016/S0361-9230(03)00073-X

Identifiers

DOI

1 reference

9 August 2017

1 reference